UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-K/A

 

Amendment No. 1

 

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the fiscal year ended December 31, 2019

 

or

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ___________ to ___________

 

Commission file number ___________

 

Legacy Acquisition Corp.

(Exact Name of Registrant as Specified in Its Charter)

 

Delaware   81-3674868
State or Other Jurisdiction of
Incorporation or Organization
  I.R.S. Employer
Identification No.
     
1308 Race Street, Suite 200
Cincinnati, Ohio
  45202
Address of Principal Executive Offices   Zip Code

 

Registrant’s telephone number, including area code (513) 618-7161

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on
which registered
Units, each consisting of one share of Class A common stock and one Warrant to purchase one-half of one share of Class A common stock   LGC U   New York Stock Exchange
Class A common stock, par value $0.0001 per share   LGC   New York Stock Exchange
Warrants, exercisable for one-half of one share of Class A common stock for $5.75 per half share, or $11.50 per whole share   LGC WS   New York Stock Exchange

 

Securities registered pursuant to Section 12(g) of the Act:

 

None

 

(Title of Class)

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.  Yes ☐    No ☒ 

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act.  Yes ☐    No ☒

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes ☒     No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  Yes ☒    No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. ☒

 

Large accelerated filer ☐ Accelerated filer ☒
Non-accelerated filer ☐  Smaller reporting company 
  Emerging growth company   

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).  Yes     No ☐ 

 

As of June 28, 2019 (the last business day of the registrant’s most recently completed second fiscal quarter), the aggregate market value of the Class A common stock held by non-affiliates of the registrant was $303,000,000 (based on the closing price of the registrant’s Class A common stock on that date as reported on the New York Stock Exchange).

 

At February 14, 2020, there were (i) 7,500,000 shares of Class F common stock, par value $0.0001 per share (“Class F common stock”), issued and outstanding, and (ii) 29,305,180 shares of Class A common stock, $0.0001 par value per share (“Class A common stock”), issued and outstanding which includes shares of Class A common stock underlying the Units sold in the registrant’s initial public offering, and of which 29,269,398 shares of Class A common stock trade separately.

 

 

 

 

 

EXPLANATORY NOTE

 

This Amendment No. 1 on Form 10-K/A to the Annual Report of Legacy Acquisition Corp. on Form 10-K for the year ended December 31, 2019, initially filed with the Securities and Exchange Commission on February 27, 2020 (the “Original Filing”), is being filed to amend Items 6 and 8 of Part II of the Original Filing as follows: (i) to revise the cash flows from investing activities to reflect the withdrawal from trust account for redemptions as cash inflows in the amount of $7,108,000 and redemptions of Class A common stock as cash outflows in financing activities in the amount of $7,108,000 in the Company’s Statement of Cash Flows included Item 8 of Part II; and (ii) to revise the Net cash flow provided by (used in) investing activities and the Net cash provided by (used in) financing activities included in Item 8 of Part II - Cash Flow Data to conform to the financial statement changes noted in section (i).

 

Except as described above, no other amendments are being made to the Original Filing. This Amendment No. 1 also includes the currently dated signature page and certifications from the Company’s principal executive officer and principal financial officer. This Amendment No. 1 does not reflect events occurring after the February 27, 2020 filing of the Original Filing or modify or update the disclosure contained in the Original Filing in any way other than to reflect the amendments discussed above. Accordingly, this Amendment No. 1 should be read in conjunction with the Original Filing and our other filings with the SEC.

 

 

 

 

TABLE OF CONTENTS

 


PART II 1
ITEM 6. SELECTED FINANCIAL DATA 1
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA 2
PART IV 5
ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES 5
ITEM 16. FORM 10-K SUMMARY 5
SIGNATURES 6

 

i

 

 

PART II

 

ITEM 6. SELECTED FINANCIAL DATA

 

The following table sets forth selected historical financial information derived from our audited financial statements included elsewhere in this report as of, and for the fiscal years ended, December 31, 2019, 2018 and 2017, respectively. You should read the following selected financial data in conjunction with “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and the financial statements and the related notes appearing elsewhere in this report.

 

Balance Sheet Data:  December 31,
2019
   December 31,
2018
   December 31,
2017
 
Cash  $568,000   $1,180,000   $1,752,000 
Cash and Investments held in Trust Account  $302,529,000   $304,035,000   $300,403,000 
Total Assets  $303,123,000   $305,268,000   $302,291,000 
Total current liabilities  $4,183,000   $607,000   $444,000 
Deferred underwriting compensation  $10,500,000   $10,500,000   $10,500,000 
Common stock subject to possible redemption (at redemption value):  $283,440,000   $289,161,000   $286,347,000 
Total stockholders’ equity (deficit)  $5,000,000   $5,000,000   $5,000,000 

 

   Year Ended December 31,
2019
   Year Ended December 31,
2018
   Year Ended to December 31,
2017
 
Cash Flow Data:            
Net cash used in operating activities  $(3,450,000)  $(2,499,000)  $(23,000)
Net cash provided by (used in) in investing activities  $

7,988,000

  $1,927,000   $(300,000,000)
Net cash provided by (used in) financing activities  $(5,150,000)  $-   $301,749,000 
                
Statement of Operations Data:               
Operating expenses:               
General and administrative expenses  $3,775,000   $1,623,000   $154,000 
Loss from operations  $(3,775,000)  $(1,623,000)  $(154,000)
Other Income:               
Interest income  $6,482,000   $5,559,000   $403,000 
Income (loss) before income taxes  $2,707,000    3,936,000    249,000 
Provision for income taxes  $(1,320,000)   (1,130,000)   (130,000)
Net income (loss) attributable to common stockholders  $1,387,000   $2,806,000   $119,000 
Two Class Method for Per Share Information:               
Weighted average class A common shares outstanding – basic and diluted   29,867,000    30,000,000    7,650,000 
Net income (loss) per share class A common stock - basic and diluted  $0.16   $0.09    0.02 
Weighted average class F common shares outstanding – basic and diluted   7,500,000    7,500,000    7,500,000 
Net (loss) per class F common shares- basic and diluted  $(0.46)  $(0.01)  $0.00 

 

1

 

  

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

 

LEGACY ACQUISITION CORP.

Index to Financial Statements

 

Report of Independent Registered Public Accounting Firm F-1
   
Balance Sheets as of December 31, 2019 and 2018 F-2
   
Statements of Operations for the years ended December 31, 2019 and 2018 F-3
   
Statements of Changes in Stockholders’ Equity for the years ended December 31, 2019 and 2018 F-4
   
Statements of Cash Flows for the years ended December 31, 2019 and 2018 F-5
   
Notes to Financial Statements F-6 – F-17

 

2

 

 

Supplementary Data (unaudited)

 

The following table presents selected unaudited quarterly financial data of the Company for the years ended December 31, 2019, 2018 and 2017.

 

   Year ended December 31, 2019 
   First
Quarter
   Second
Quarter
   Third
Quarter
   Fourth
Quarter
   Year Ended
December 31,
2019
 
                     
Operating Expenses:                    
General and Administrative Expenses  $262,000   $1,094,000   $1,210,000   $1,209,000   $3,775,000 
Loss from operations   (262,000)   (1,094,000)   (1,210,000)   (1,209,000)   (3,775,000)
Other Income – Interest on Trust   1,761,000    1,805,000    1,588,000    1,328,000    6,482,000 
Income before income tax   1,499,000    711,000    378,000    119,000    2,707,000 
Provision for income tax   (360,000)   (370,000)   (325,000)   (265,000)   (1,320,000)
Net Income  $1,139,000   $341,000   $53,000   $(146,000)  $1,387,000 
Two class Method for Per Share Information:                         
Weighted average Class A shares outstanding – basic and diluted   30,000,000    30,000,000    30,000,000    29,305,000    2,865,000 
Net income (loss) per class A common shares outstanding – basic and diluted  $0.04   $0.05   $0.04   $0.02   $0.16 
Weighted average class F shares outstanding – basic and diluted   7,500,000    7,500,000    7,500,000    7,500,000    7,500,000 
Net income per class F common shares outstanding – basic and diluted  $(0.03)  $(0.14)  $(0.15)  $(0.14)  $(0.46)
                          
Balance Sheet Data (at period end)                         
Cash  $2,229,000   $1,385,000   $740,000   $568,000   $568,000 
Investments and cash held in trust  $304,351,000   $305,690,000   $306,852,000   $302,529,000   $302,529,000 
Total Assets  $306,668,000   $307,161,000   $307,699,000   $303,123,000   $303,123,000 
Deferred underwriting fee  $10,500,000   $10,500,000   $10,500,000   $10,500,000   $10,500,000 
Total Liabilities  $11,368,000   $11,520,000   $12,005,000   $14,683,000   $14,683,000 
Common stock subject to possible redemption  $290,300,000   $290,641,000   $-290,694,000   $283,440,000   $283,440,000 
Equity  $5,000,000   $5,000,000   $5,000,000   $5,000,000   $5,000,000 

 

3

 

 

   Year ended December 31, 2018 
   First
Quarter
   Second
Quarter
   Third
Quarter
   Fourth
Quarter
   Year Ended
December 31,
2018
 
                     
Operating Expenses:                    
General and Administrative Expenses  $287,000   $270,000   $211,000   $855,000   $1,623,000 
Loss from operations   (287,000)   (270,000)   (211,000)   (855,000)   (1,623,000)
Other Income – Interest on Trust   1,076,000    1,279,000    1,522,000    1,682,000    5,559,000 
Income before income tax   789,000    1,009,000    1,311,000    827,000    3,936,000 
Provision for income tax   (215,000)   (220,000)   (330,000)   (365,000)   (1,130,000)
Net Income  $574,000   $789,000   $981,000   $462,000   $2,806,000 
Two class Method for Per Share Information:                         
Weighted average Class A shares outstanding – basic and diluted   30,000,000    30,000,000    30,000,000    30,000,000    30,000,000 
Net income (loss) per class A common shares outstanding – basic and diluted  $(0.00)  $(0.03)  $(0.03)  $0.02   $0.09 
Weighted average class F shares outstanding – basic and diluted   7,500,000    7,500,000    7,500,000    7,500,000    7,500,000 
Net income per class F common shares outstanding – basic and diluted  $0.02   $0.00   $0.00   $0.00   $0.00 
                          
Balance Sheet Data (at period end)                         
Cash  $1,306,000   $1,813,000   $1,437,000   $1,180,000   $1,180,000 
Investments and cash held in trust  $301,480,000   $301,332,000   $302,854,00   $304,035,000   $304,035,000 
Total Assets  $302,957,000   $303,276,000   $304,382,000   $305,268,000   $305,268,000 
Deferred underwriting fee  $10,500,000   $10,500,000   $10,500,000   $10,500,000   $10,500,000 
Total Liabilities  $11,028,000   $10,558,000   $10,683,000   $11,107,000   $11,107,000 
Common stock subject to possible redemption  $286,929,000   $287,718,000   $-288,699,000   $289,161,000   $289,161,000 
Equity  $5,000,000   $5,000,000   $5,000,000   $5,000,000   $5,000,000 

 

   Year ended December 31, 2017 
   First
Quarter
   Second
Quarter
   Third
Quarter
   Fourth
Quarter
   Year Ended
December 31,
2017
 
                     
Operating Expenses:                    
General and Administrative Expenses  $27,000   $20,000   $14,000   $93,000   $154,000 
Loss from operations   (27,000)   (20,000)   (14,000)   (93,000)   (154,000)
Other Income – Interest on Trust   -              403,000    403,000 
Income (loss) before income tax   (27,000)   (20,000)   (14,000)   310,000    249,000 
Provision for income tax   -    -    -    (130,000)   (130,000)
Net Income (Loss)  $(27,000)  $(20,000)  $(14,000)  $180,000   $119,000 
Two class Method for Per Share Information:                         
Weighted average Class A shares outstanding – basic and diluted                  30,000,000    30,000,000 
Net income per class A common shares outstanding – basic and diluted  $-   $-   $-   $0.00   $0.00 
Weighted average shares outstanding:  $-   $-   $-   $0.00   $0.00 
Net income per class F common shares outstanding – basic and diluted   7,500,000    7,500,000    7,500,000    7,702,000    7,650,000 
                          
Balance Sheet Data (at period end)                         
Cash  $80,000   $71,000   $44,000   $1,752,000   $1,752,000 
Investments and cash held in trust  $-   $-   $-   $300,403,000   $300,403,000 
Total Assets  $302,000   $310,000   $360,000   $302,291,000   $302,291,000 
Deferred underwriting fee  $-   $-   $-   $10,500,000   $10,500,000 
Total Liabilities  $464,000   $492,000   $199,000   $10,936,000   $10,936,000 
Common stock subject to possible redemption  $-   $-   $-   $286,355,000   $286,355,000 
Equity(deficit)  $(162,000)  $(182,000)  $(199,000)  $5,000,000   $5,000,000 

 

4

 

  

Report of Independent Registered Public Accounting Firm

 

To the Stockholders and the Board of Directors of

Legacy Acquisition Corp.

 

Opinion on the Financial Statements

 

We have audited the accompanying balance sheets of Legacy Acquisition Corp. (the “Company”) as of December 31, 2019 and 2018, the related statements of operations, changes in stockholders’ equity and cash flows, for the years ended December 31, 2019 and 2018 and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2019 and 2018, and the results of its operations and its cash flows for the years ended December 31, 2019 and 2018, in conformity with accounting principles generally accepted in the United States of America.

 

Going Concern

 

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 3 to the financial statements, if the Company is unable to raise additional funds to alleviate liquidity needs and does not complete a business combination by March 21, 2020 (and thereafter by up to two additional 30-day periods), then the Company will cease all operations except for the purpose of winding down and liquidating. The mandatory liquidation and subsequent dissolution and unfavorable liquidity condition raise substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Basis for Opinion

 

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audit we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the entity’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

/s/ WithumSmith+Brown, PC

 

We have served as the Company’s auditor since 2016.

Whippany, New Jersey

February 27, 2020

 

F-1

 

 

LEGACY ACQUISITION CORP.

 

BALANCE SHEETS

 

   December 31, 
   2019   2018 
ASSETS        
Current assets –        
Cash  $568,000   $1,180,000 
Prepaid expenses and other assets   26,000    53,000 
Total current assets   594,000    1,233,000 
           
Non-current assets –          
Cash and investments held in Trust Account   302,529,000    304,035,000 
           
Total assets  $303,123,000   $305,268,000 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY          
Current liabilities –          
Accounts payable  $358,000   $17,000 
Accrued expenses   1,859,000    365,000 
Accrued franchise and income taxes   8,000    225,000 
Due to related party   1,958,000    
-
 
Total current liabilities   4,183,000    607,000 
           
Other liabilities –          
Deferred underwriting compensation   10,500,000    10,500,000 
Total liabilities   14,683,000    11,107,000 
           
Common stock subject to possible redemption; 28,344,013 and 28,916,141 shares, respectively, at December 31, 2019 and 2018 (at approximately $10.00 per share)   283,440,000    289,161,000 
           
Commitments and contingencies   
 
    
 
 
           
Stockholders’ equity:          
Preferred stock, $0.0001 par value; 1,000,000 shares authorized, none issued or outstanding   
-
    
-
 
Class A Common stock, $0.0001 par value, 100,000,000 authorized shares, 30,000,000 shares issued at December 31, 2019 and 2018, 961,167 and 1,083,859 shares, respectively, outstanding (excluding 28,344,013 and 28,916,141 shares, respectively, subject to possible redemption at December 31, 2019 and 2018)   
-
    
-
 
Class F Common stock, $0.0001 par value, 10,000,000 authorized shares, 7,500,000 shares issued and outstanding   1,000    1,000 
Additional paid-in-capital   847,000    2,234,000 
Retained earnings   4,152,000    2,765,000 
Total stockholders’ equity   5,000,000    5,000,000 
Total liabilities and stockholders’ equity  $303,123,000   $305,268,000 

 

See accompanying notes to financial statements

 

F-2

 

 

LEGACY ACQUISITION CORP.

 

STATEMENTS OF OPERATIONS

 

   Year ended December 31, 
   2019   2018 
         
Revenues  $
-
   $
-
 
General and administrative expenses   3,775,000    1,623,000 
Loss from operations   (3,775,000)   (1,623,000)
           
Interest income on Trust Account   6,482,000    5,559,000 
Income before income taxes   2,707,000    3,936,000 
           
Provision for income taxes   (1,320,000)   (1,130,000)
           
Net income  $1,387,000   $2,806,000 
           
Two Class Method for Per Share Information:          
Weighted average class A common shares outstanding – basic and diluted   29,867,000    30,000,000 
           
Net income per class A common share – basic and diluted  $0.16   $0.10 
           
Weighted average class F common shares outstanding – basic and diluted   7,500,000    7,500,000 
           
Net (loss) per class F common share – basic and diluted  $(0.46)  $(0.01)

 

See accompanying notes to financial statements

 

F-3

 

 

LEGACY ACQUISITION CORP.

 

STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

For the years ended December 31, 2019 and 2018

 

                       Retained     
   Common Stock   Additional   Earnings     
   Class A       Class F       Paid-in   (Accumulated   Stockholders’ 
   Shares   Amount   Shares   Amount   Capital   Deficit)   Equity 
Balances, December 31, 2017   1,364,474   $
      -
    7,500,000   $1,000   $5,040,000   $(41,000)  $5,000,000 
                                    
Change in Class A common stock subject to possible redemption   (280,615)   
-
    
-
    
-
    (2,806,000)   
-
    (2,806,000)
                                    
Net income   -    
-
    -    
-
    
-
    2,806,000    2,806,000 
                                    
Balances, December 31, 2018   1,083,859    
-
    7,500,000    1,000    2,234,000    2,765,000    5,000,000 
                                    
Shares redeemed at $10.23 per share in October 2019 (Notes 2 and 6)   (694,820)   
-
    
-
    
-
    (7,108,000)   
-
    (7,108,000)
                                    
Change in Class A common stock subject to possible redemption   572,128    
-
    
-
    
-
    5,721,000    
-
    5,721,000 
                                    
Net income   -    
-
    -    
-
    
-
    1,387,000    1,387,000 
                                    
Balances, December 31, 2019   961,167   $
-
    7,500,000   $1,000   $847,000   $4,152,000   $5,000,000 

 

See accompanying notes to financial statements

 

F-4

 

 

LEGACY ACQUISITION CORP.

 

STATEMENTS OF CASH FLOWS

 

   Year ended December 31, 
   2019   2018 
         
Net income  $1,387,000   $2,806,000 
Adjustments to reconcile net income to net cash used in operating activities:          
Interest income earned on Trust Account   (6,482,000)   (5,559,000)
Changes in operating assets and liabilities:          
Increase (decrease) in accounts payable   341,000    (169,000)
Increase in accrued expenses   1,494,000    270,000 
Decrease (increase) in accrued franchise and income taxes   (217,000)   70,000 
(Increase) decrease in prepaid expenses, rounding and other   27,000    83,000 
Net cash used in operating activities   (3,450,000)   (2,499,000)
           
Cash flows from investing activities –          
Withdrawal from Trust Account for redemption of Class A common stock   7,108,000    
-
 
Deposit a portion of related party loans in Trust Account   (1,758,000)   
-
 
Withdrawal from Trust Account for taxes and working capital   2,638,000    1,927,000 
Net cash provided by investing activities   7,988,000    1,927,000 
           
Cash flows from financing activities –          
Redemption of Class A common stock   (7,108,000)     
Proceeds from related party loans   1,958,000    
-
 
Net cash used in financing activities   (5,150,000)   
-
 
           
Net decrease in cash   (612,000)   (572,000)
Cash at beginning of year   1,180,000    1,752,000 
Cash at end of year  $568,000   $1,180,000 
           
Supplemental disclosure of non-cash financing activities:          
Cash paid for income taxes  $1,397,000   $1,215,000 
           
Change in value of common stock subject to possible redemption  $(5,721,000)  $2,806,000 

 

See accompanying notes to financial statements

 

F-5

 

 

LEGACY ACQUISITION CORP.

 

Notes to Financial Statements

 

NOTE 1 – DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS

 

Organization and General:

 

Legacy Acquisition Corp. (the “Company”) was incorporated in Delaware on March 15, 2016. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, or the “Securities Act,” as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”).

 

At December 31, 2019, the Company had not commenced any operations. All activity for the period from March 15, 2016 (inception) through December 31, 2019 relates to the Company’s formation and the initial public offering (“Public Offering”) described below, and subsequent to the Public Offering, searching for a potential business combination. The Company will not generate any operating revenues until after completion of the initial Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds derived from the Public Offering.

 

Sponsor and Financing:

 

The Company’s sponsor is Legacy Acquisition Sponsor I LLC, a Delaware limited liability company (the “Sponsor”). The registration statement for the Company’s Public Offering (as described in Note 4) was declared effective by the United States Securities and Exchange Commission (the “SEC”) on November 16, 2017. The Company intends to finance a Business Combination with the net proceeds from a $300,000,000 Public Offering (Note 4) and a $8,750,000 private placement (Note 5). Upon the closing of the Public Offering and the private placement, $300,000,000 is held in the Trust Account with Continental Stock Transfer and Trust Company (the “Trustee”) acting as the trustee (the “Trust Account”) (as discussed below). See Notes 2 and 6 below regarding approximately $7,108,000 of shareholder redemptions (694,820 shares) paid from the Trust Account in October 2019 in connection with the Extension Amendment, defined below, that extends the date to complete a Business Combination as described therein.

 

The Trust Account:

 

Funds from the Public Offering have been placed in the Trust Account. The Trust Account will be invested only in U.S. government treasury bills with a maturity of one hundred and eighty (185) days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act of 1940 which invest only in direct U.S. government obligations. Funds will remain in the Trust Account until the earlier of (i) the consummation of the Business Combination or (ii) the distribution of the Trust Account as described below. The remaining proceeds outside the Trust Account may be used to pay for business, legal and accounting due diligence on prospective Business Combinations and continuing general and administrative expenses.

 

The Company’s amended and restated certificate of incorporation provides that, other than the withdrawal of interest to pay taxes and up to $750,000 per year for working capital purposes, if any, none of the funds held in trust may be released until the earlier of: (i) the completion of the initial Business Combination; or (ii) the redemption of any public shares properly tendered in connection with a stockholder vote to amend the Company’s amended and restated certificate of incorporation to modify the substance and timing or the Company’s obligation to redeem 100% of its public shares if the Company does not complete its initial business combination by the Outside Extended Date or (iii) the redemption of 100% of the shares of Class A common stock included in the Units sold in the Public Offering if the Company is unable to complete a Business Combination by the Outside Extended Date (subject to the requirements of law). See Note 2 below regarding the Extension Amendment that extends the date to complete a business combination and certain shareholder redemptions paid from the Trust Account as described therein. The Company may continue to withdraw from the Trust Account amounts necessary for taxes, and for working capital of up to $750,000 annually (on a pro rata basis), during the period of the Extension Amendment discussed in Note 2.

 

F-6

 

 

Business Combination:

 

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Public Offering, although substantially all of the net proceeds of the Public Offering are intended to be generally applied toward consummating a Business Combination with (or acquisition of) a Target Business. As used herein, “Target Business” means one or more target businesses that together have a fair market value equal to at least 80% of the balance in the Trust Account (less any deferred underwriting commissions and taxes payable on interest earned) at the time of the signing of a definitive agreement in connection with the Business Combination. Furthermore, there is no assurance that the Company will be able to successfully effect a Business Combination within 24 months from the closing of the Public Offering, as extended in the Extension Amendment that is further discussed in Note 2 below, if at all.

 

The Company, after signing a definitive agreement for an initial Business Combination, will either (i) seek stockholder approval of the Business Combination at a meeting called for such purpose in connection with which stockholders holding Class A common stock may seek to redeem their shares, regardless of whether they vote for or against the Business Combination, for cash equal to their pro rata share of the aggregate amount then on deposit in the Trust Account as of two business days prior to the consummation of the initial Business Combination, including interest but less taxes payable and up to $750,000 per year which may be, and has been, released for working capital purposes, or (ii) provide stockholders holding Class A common stock with the opportunity to sell their shares to the Company by means of a tender offer (and thereby avoid the need for a stockholder vote) for an amount in cash equal to their pro rata share of the aggregate amount then on deposit in the Trust Account as of two business days prior to commencement of the tender offer, including interest but less taxes payable and up to $750,000 per year which may have been released for working capital. The decision as to whether the Company will seek stockholder approval of the initial Business Combination or will allow stockholders to sell their shares in a tender offer will be made by the Company, solely in its discretion, and will be based on a variety of factors such as the timing of the transaction and whether the terms of the transaction would otherwise require the Company to seek stockholder approval unless a vote is required by New York Stock Exchange (“NYSE”) rules. If the Company seeks stockholder approval, it will complete its Business Combination only if a majority of the outstanding shares of common stock voted are voted in favor of the Business Combination. However, in no event will the Company redeem its public shares of Class A common stock in an amount that would cause its net tangible assets to be less than $5,000,001 upon consummation of the Business Combination. In such case, the Company would not proceed with the redemption of its public shares of Class A common stock and the related Business Combination, and instead may search for an alternate Business Combination.

 

If the Company holds a stockholder vote or there is a tender offer for shares in connection with a Business Combination, a public stockholder will have the right to redeem its Class A common stock for an amount in cash equal to such stockholder’s pro rata share of the aggregate amount then on deposit in the Trust Account as of two business days prior to the consummation of the initial Business Combination, including interest but less taxes payable and up to $750,000 per year which may have been released to the Company to fund working capital requirements. As a result, such shares of Class A common stock are recorded at redemption amount and classified as temporary equity in the accompanying balance sheet, in accordance with FASB ASC 480, “Distinguishing Liabilities from Equity.”

 

The Company only had 24 months from the closing date of the Public Offering to complete its initial Business Combination. However, as discussed further in Note 2 below, on October 22, 2019, the shareholders of the Company approved the extension of time to complete the Business Combination, as defined in Note 2, from November 21, 2019 to December 21, 2019 and thereafter at the Company’s option or upon the Sellers request up to five times, initially to January 21, 2020, and thereafter by up to four additional 30-day periods ending on May 20, 2020. The Company has currently exercised three extension options, (i) from December 21, 2019 to January 21, 2020, (ii) from January 21, 2020 to February 20, 2020 and (iii) from February 20, 2020 to March 21, 2020. If the Company does not complete a Business Combination within this extended period of time, it shall (i) cease all operations except for the purposes of winding up; (ii) as promptly as reasonably possible, but not more than ten business days thereafter, redeem the public shares of Class A common stock for a per share pro rata portion of the Trust Account, including interest, but less taxes payable and up to $750,000 per year which may be, and has been, released for working capital (less up to $50,000 of such net interest to pay dissolution expenses) and (iii) as promptly as possible following such redemption, dissolve and liquidate the balance of the Company’s net assets to its remaining stockholders, as part of its plan of dissolution and liquidation. The initial stockholder has entered into a letter agreement with the Company, pursuant to which it has waived its right to participate in any redemption with respect to its initial shares; however, if the initial stockholder or any of the Company’s officers, directors or affiliates acquire shares of Class A common stock after the Public Offering, they will be entitled to a pro rata share of the Trust Account, with respect to such public shares, upon the Company’s redemption or liquidation in the event the Company does not complete a Business Combination within the required time period.

 

F-7

 

 

In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be less than the initial public offering price per Unit in the Public Offering.

 

Going Concern

 

In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standard Board’s Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern”, management has determined that the mandatory liquidation and subsequent dissolution, as well as the Company’s negative working capital position, raises substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after February 20, 2020 and thereafter at the Company’s option or upon the Sellers request up to four additional 30-day periods, as extended (as discussed in Note 2).

 

NOTE 2 – SHARE EXCHANGE AGREEMENT FOR BUSINESS COMBINATION AND EXTENSION AMENDMENT

 

On August 23, 2019, the Company entered into a Share Exchange Agreement (the “Share Exchange Agreement”) with Blue Valor Limited, a company incorporated in Hong Kong and an indirect, wholly-owned subsidiary of Blue Focus Intelligent Communications Group (“Blue Valor” or the “Seller”), pursuant to which, subject to the satisfaction or waiver of certain conditions set forth therein, the Company will, among other things, purchase from the Seller all of the outstanding shares of stock of a wholly-owned holding company organized in the Cayman Islands, Blue Impact (Cayman) Limited that, at the closing, will hold the Blue Impact group business, a digital-first, intelligent and integrated global advertising and marketing services company (the “Blue Impact” business). The Share Exchange Agreement was subsequently amended by that First Amendment to Share Exchange Agreement dated as of September 27, 2019, to amend certain provisions relating to the Extension Amendment, and further amended and restated on December 2, 2019, pursuant to which, subject to the satisfaction or waiver of certain conditions set forth therein, the Seller will transfer all of the equity interests of its wholly-owned subsidiary, Blue Impact Target, in exchange for shares of Legacy. Upon the closing of the Business Combination, the Company will change its name to Blue Impact Inc.

 

For more information about the transactions contemplated by the Share Exchange Agreement, please see the Current Report on Form 8-K filed with the Securities and Exchange Commission on August 27, 2019 and the Definitive Proxy Statement filed on September 30, 2019.

 

Pursuant to the Share Exchange Agreement, at the closing, the Seller will receive up to 30 million shares of Class A common stock of the Company, subject to adjustment as set forth below (the “Closing Shares”), and Legacy expects to (a) assume $40 million of net debt related to the Blue Impact business, (b) assume $48 million of deferred acquisition purchase price obligations, and (c) pay $90 million to purchase or redeem certain minority interests of one of the Blue Impact businesses (“Madhouse”).

 

F-8

 

 

The Closing Shares will be subject to adjustment following closing based on the extent to which, as of the closing date, (a) the net debt of the Blue Impact business, (b) the deferred acquisition purchase price obligations for the Blue Impact business (excluding Madhouse) and (c) the amount of the purchase price for the minority interests of Madhouse, are each finally determined to be greater or less than the targets for such amounts specified in the Share Exchange Agreement. The determinations as of the closing date of the foregoing amounts will be mutually agreed to by the Seller and a committee of independent directors of the Company with any disagreements being resolved by a nationally recognized independent public accounting firm jointly selected by the Seller and the Company.

 

Pursuant to an “earn-out” for Madhouse, up to $222 million may be payable after the 2022 audit is complete in the form of an incentive-based earn-out tied to average profit growth of the Madhouse business over the three-year period ending December 31, 2022. The earn-out will be payable at the Company’s option in cash, stock or a combination thereof if Company’s common stock share price at the time of payment is greater than $10 per share. If not, then dependent upon the Company’s then-available cash, the earn-out will be payable in cash or subordinated notes. The Seller has partially and irrevocably assigned a portion of any earn-out payment to fund a long-term incentive plan to be established for the benefit of designated individuals employed or associated with the group company business.

 

The Company’s Charter and final IPO prospectus dated November 16, 2017, (which was filed with the SEC on November 17, 2017) provided that the Company had until November 21, 2019 to complete a business combination. In order to provide the Company additional time to complete the Business Combination, on October 22, 2019 the Company’s shareholders approved an Extension Amendment (the “Extension Amendment”) in order to extend the deadline to complete the Business Combination from November 21, 2019 to December 21, 2019 and thereafter at the Company’s option or upon the Sellers request up to five times, initially to January 21, 2020, and thereafter by up to four additional 30-day periods ending on May 20, 2020. The deadline to consummate the Business Combination is currently extended to March 21, 2020. While the purpose of the Extension Amendment is to allow the Company more time to complete the proposed Business Combination, if the Business Combination is terminated the Company may seek to use the Extension to complete an alternative business combination. The Company may continue to withdraw from the Trust Account amounts necessary for taxes, and for working capital of up to $750,000 annually (on a pro rata basis), during the period of the Extension Amendment.

 

On October 23, 2019, the Company issued a note (the “Seller Note”) for the aggregate principal amount of approximately $979,000, to the Seller (including $100,000 provided to the Company for working capital). Borrowings under the Seller Note will bear interest at a rate equal to the 1-month USD LIBOR interest rate, plus 1.5%. The Seller Note was issued in connection with the approval by the Company’s stockholders of the Extension Amendment. In connection with the Extension Amendment, stockholders elected to redeem 694,820 shares of the Company’s Class A common stock, par value $0.0001 per share, issued in the Company’s initial public offering (the “public shares”), and 29,305,180 public shares remain issued and outstanding following such redemptions. Accordingly, consistent with the Company’s proxy materials relating to the special meeting, on or about October 23, 2019, the Company made a cash contribution to the Trust Account in an amount equal to $0.03 for each public share that was not redeemed in connection with the stockholder approval of the Extension Amendment for the initial extension through December 21, 2019, which equaled an aggregate amount of approximately $979,000 (including $100,000 provided to Company for costs and expenses). On December 17, 2019, in connection with the Company’s extension of the date by which the Company has to consummate a business combination from December 21, 2019, to January 21, 2020, the Company issued an amended and restated note (the “Amended Seller Note”) to the Seller that amended and restated the Seller Note and received the second Seller Loan from the Seller. Borrowings under the Amended Seller Note will continue to bear interest at a rate equal to the 1 month USD LIBOR interest rate, plus 1.5% accruing from the date of the applicable borrowings. Subsequent to December 31, 2019, the Company has extended the date by which it has to consummate a business combination from January 21, 2020 to February 20, 2020, and from February 20, 2020 to March 21, 2020. In connection with each of the first three extensions, the Seller loaned $979,155.40 to the Company under the Amended Seller Note. Additionally, in connection with the fourth and most recent extension, the Seller loaned $879,155.40. As a result, Seller will have loaned to the Company a total aggregate amount of $3,816,621.60.

 

F-9

 

 

Under the terms of the Share Exchange Agreement, the Seller agreed to loan (each, a “Seller Loan”) to Legacy the amount of the contributions to be made by Legacy in connection with the initial extension through December 21, 2019, and for each period of the Extension thereafter; provided, however, that the Seller is not be required to make any loan to Legacy with respect to any Extension for the purpose of consummating an initial business combination other than the Business Combination. In addition, the Seller agreed that the Seller Loans may include additional amounts to cover certain costs and expenses that Legacy will reasonably incur in connection with the continuation of operations until the earlier of the consummation of the Business Combination or the Extended Date and the total of all such costs and expenses shall not exceed a total of $300,000 in the aggregate for all Extensions through the Extended Date. No Seller Loan may exceed $1,000,000 in the aggregate (including loans to fund costs and expenses). The Seller Loans made on or about October 23, 2019, December 21, 2019 and January 21, 2020,, each in the principal amount of approximately $979,000 under the Amended Seller Note reflects a loan to fund the Company’s Contributions to the Trust Account of approximately $879,000 plus $100,000 to fund the costs and expenses that the Company reasonably expects incur in connection with the continuation of operations until the earlier of the consummation of the Business Combination or the Extended Date. As of January 21, 2020, Legacy had borrowed in respect of its costs and expenses a total of $300,000 in the aggregate.

 

The Seller Loans will be forgiven by the Seller if the closing of the Business Combination does not occur and the Trust Account liquidates, except to the extent of any funds that are available to the Company (i) after such liquidation in accordance with the trust agreement, or (ii) from any other source. The amount of the Seller Loans will be repayable by the Company to the Seller upon consummation of the Business Combination.

 

When the Company elected and/or the Seller requested that the Company extend the date by which the Company has to consummate the Business Combination, the Company has (and will) publicly announce the Company’s decision no later than the close of business on the last day of the then-current extension period. In addition, the Company has (and will) make additional Contributions of $0.03 per outstanding public share for each period of the extension by Legacy at its option and/or at the Seller’s request. The Seller has so far made Contributions of $979,155.40 for each of the first three extensions, and $879,155.40 for the fourth and most recent extension to March 21, 2020, for Contributions of a total aggregate amount of $3,816,621.60. If the Company elects and/or the Seller requests that the Company extend the date for either or both of the two remaining 30-day extension periods, the Seller would make Contributions of approximately $879,000, respectively. If, however, the Seller does not request that we extend beyond March 21, 2020 or any additional 30-day period thereafter and the Company also determines not to extend or our board of directors otherwise determines that the Company will not be able to consummate an initial business combination by the Extended Date and does not wish to have an additional Extension, the Company’s board of directors would wind up our affairs and redeem 100% of the outstanding public shares.

 

NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation:

 

The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the accounting and disclosure rules and regulations of the Securities and Exchange Commission (“SEC”).

 

All dollar amounts are rounded to the nearest thousand dollars.

 

Emerging Growth Company

 

Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.

 

F-10

 

 

Net Income (Loss) per Common Share

 

Net income (loss) per common share is computed by dividing net income (loss) applicable to common stockholders by the weighted average number of common shares outstanding for the periods. The Company has not considered the effect of the warrants sold in the initial public offering and private placement to purchase an aggregate of 23,750,000 Class A ordinary shares in the calculation of diluted income (loss) per share, since their inclusion would be anti-dilutive under the treasury stock method. As a result, diluted income (loss) per common share is the same as basic loss per common share for the periods.

  

The Company’s statements of operations include a presentation of income (loss) per share for common stock subject to redemption in a manner similar to the two-class method of income (loss) per share. Net income (loss) per common share, basic and diluted for Class A common stock is calculated by dividing the interest income earned on the Trust Account, net of income tax expense, franchise tax expense and funds available to be withdrawn from Trust for working capital purposes (up to a maximum of $750,000 annually), by the weighted average number of Class A common stock outstanding for the period. Net income (loss) per common share, basic and diluted, for Class F common stock is calculated by dividing the net income (loss), less income attributable to Class A Common Stock, by the weighted average number of Class F common stock outstanding for the period. Net income (loss) available to each class of common stockholders is as follows for the years ended December 31, 2019 and 2018:

 

   Year ended 
   December 31, 
   2019   2018 
         
Net income available to Class A common stockholders:        
Interest income  $6,482,000    5,559,000 
Less:  Income and franchise taxes   (1,520,000)   (1,330,000)
Expenses available to be paid with interest income from Trust (up to a maximum of $750,000 per year)   (125,000)   (1,372,000)
Net income available to Class A common stockholders  $4,837,000   $2,857,000 
           
Net income available to Class F common stockholders:          
Net income  $1,387,000   $2,806,000 
Less: amount attributable to Class A common stockholders   (4,837,000)   (2,857,000)
Net (loss) available to class F common stockholders  $(3,450,000)  $(51,000)

 

Concentration of Credit Risk:

 

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which at times, may exceed the Federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.

 

F-11

 

 

Financial Instruments:

 

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the financial statements.

 

Use of Estimates:

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenue and expenses during the reporting periods. Actual results could differ from those estimates.

 

Deferred Offering Costs:

 

The Company complies with the requirements of the ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (SAB) Topic 5A – “Expenses of Offering.” Offering costs of approximately $17,379,000 consisted principally of underwriter discounts of $16,500,000 (including $10,500,000 of which payment is deferred) and approximately $887,000 of professional, printing, filing, regulatory and other costs, have been charged to additional paid-in-capital upon completion of the Public Offering.

 

Income Taxes:

 

The Company follows the asset and liability method of accounting for income taxes under FASB ASC, 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

 

The Company’s currently taxable income consists of interest income on the Trust Account net of franchise taxes. The Company’s general and administrative costs are generally considered start-up costs and are not currently deductible. The Company recorded income tax expense of approximately $1,320,000 and $1,130,000, respectively, in the years ended December 31, 2019 and 2018, primarily related to interest income earned on the Trust Account net of franchise taxes. The Company’s effective tax rate was approximately 49 % and 29%, respectively, for each of the years ended December 31, 2019 and 2018. The Company’s effective tax rate differs from the expected income tax rate due to the start-up costs (discussed above) which are not currently deductible. At December 31, 2019 and 2018, the Company has a deferred tax asset of approximately $1,080,000 and $355,000, respectively, primarily related to start-up costs. Management has determined that a full valuation allowance of the deferred tax asset is appropriate at this time.

 

FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of December 31, 2019 and 2018. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties at December 31, 2019 and 2018. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.

 

F-12

 

 

Redeemable Common Stock:

 

As discussed in Note 4, all of the 30,000,000 common shares sold as part of a Unit in the Public Offering (694,820 of which were redeemed in October 2019 as discussed in Note 2 above leaving 29,305,180 outstanding) contain a redemption feature which allows for the redemption of common shares under the Company’s Liquidation or Tender Offer/Stockholder Approval provisions. In accordance with FASB 480, redemption provisions not solely within the control of the Company require the security to be classified outside of permanent equity. Ordinary liquidation events, which involve the redemption and liquidation of all of the entity’s equity instruments, are excluded from the provisions of FASB ASC 480. Although the Company did not specify a maximum redemption threshold, its charter provides that in no event will it redeem its Public Shares in an amount that would cause its net tangible assets (stockholders’ equity) to be less than $5,000,001.

 

The Company recognizes changes immediately as they occur and adjusts the carrying value of the securities at the end of each reporting period. Increases or decreases in the carrying amount of redeemable common stock are affected by adjustments to additional paid-in capital. Accordingly, at December 31, 2019 and 2018, 28,344,013 and 28,916,141, respectively, of the 30,000,000 Public Shares (29,305,180 of which were outstanding at December 31, 2019) were classified outside of permanent equity.

 

Recent Accounting Pronouncements:

 

Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.

 

Subsequent Events:

 

Management has evaluated subsequent events to determine if events or transactions occurring after the date of the financial statements but before the financial statements were issued, require potential adjustment to or disclosure in the financial statements and has concluded that all such events that would require adjustment or disclosure have been recognized or disclosed.

  

NOTE 4 – PUBLIC OFFERING

 

On November 21, 2017, the Company closed on the Public Offering and sale of 30,000,000 units at a price of $10.00 per unit (the “Units”). Each Unit consists of one share of the Company’s Class A common stock, $0.0001 par value and one redeemable common stock purchase warrant (the “Warrants”). Under the terms of a warrant agreement, the Company has agreed to use its best efforts to file a new registration statement under the Securities Act, following the completion of the initial Business Combination. Each Warrant entitles the holder to purchase one half of one share of Class A common stock at a price of $5.75 (11.50 per whole share). No fractional shares will be issued upon exercise of the warrants. If, upon exercise of the warrants, a holder would be entitled to receive a fractional interest in a share, the Company will, upon exercise, round down to the nearest whole number the number of shares of Class A common stock to be issued to the warrant holder. Each Warrant will become exercisable on the later of 30 days after the completion of the Company’s initial Business Combination or 12 months from the closing of the Public Offering and will expire five years after the completion of the Company’s initial Business Combination or earlier upon redemption or liquidation. However, if the Company does not complete its initial Business Combination on or prior to the 24-month period allotted to complete the Business Combination, the Warrants will expire at the end of such period. If the Company is unable to deliver registered shares of Class A common stock to the holder upon exercise of Warrants issued in connection with the 30,000,000 public units during the exercise period, there will be no net cash settlement of these Warrants and the Warrants will expire worthless, unless they may be exercised on a cashless basis in the circumstances described in the warrant agreement. Once the warrants become exercisable, the Company may redeem the outstanding warrants in whole and not in part at a price of $0.01 per warrant upon a minimum of 30 days’ prior written notice of redemption, only in the event that the last sale price of the Company’s shares of common stock equals or exceeds $18.00 per share for any 20 trading days within the 30-trading day period ending on the third trading day before the Company sends the notice of redemption to the warrant holders.

 

F-13

 

 

The Company granted the underwriters in the Public Offering a 45-day option to purchase up to 4,500,000 additional Units to cover any over-allotment, at the initial public offering price less the underwriting discounts and commissions. On November 27, 2017, the Company was advised by the underwriters’ that the overallotment option would not be exercised. As such, the 1,125,000 shares subject to forfeiture which are described in Note 5 were forfeited.

 

The Company paid an underwriting discount of 2% of the per Unit offering price to the underwriters at the closing of the Public Offering ($6,000,000), with an additional fee (the “Deferred Discount”) of 3.5% of the gross offering proceeds ($10,500,000) payable upon the Company’s completion of a Business Combination. The Deferred Discount will become payable to the underwriters from the amounts held in the Trust Account solely in the event the Company completes its initial Business Combination.

 

See Notes 2 and 6 regarding the 694,820 shares redeemed for approximately $7,108,000 at October 22, 2019 in connection with the Extension Amendment.

 

NOTE 5 – RELATED PARTY TRANSACTIONS

 

Founder Shares

 

In October 2016, the Sponsor purchased 8,625,000 shares of Class F common stock (the “Founder Shares”) for $25,000, or approximately $0.001 per share (see Note 7). The Founder Shares are identical to the Class A common stock included in the Units being sold in the Public Offering except that the Founder Shares are convertible under the circumstances described below and subject to certain transfer restrictions, as described in more detail below. The Sponsor agreed to forfeit up to 1,125,000 Founder Shares to the extent that the over-allotment option was not exercised in full by the underwriters (see Notes 5 and 7) so that the initial stockholder would own 20.0% of the Company’s issued and outstanding shares after the Public Offering. As discussed further in Notes 5 and 7, on November 27, 2017, the underwriters’ notified the Company that they would not exercise the overallotment option and, as such, the 1,125,000 shares that were subject to forfeiture were forfeited as of the closing of the Public Offering on November 21, 2017. The Founder Shares will automatically convert into shares of Class A common stock at the time of the Business Combination on a one-for-one basis, subject to adjustment as described in the Company’s amended and restated certificate of incorporation.

  

The Company’s initial stockholder has agreed not to transfer, assign or sell any of its Founder Shares until the earlier of (A) one year after the completion of the Company’s initial Business Combination, or earlier if, subsequent to the Company’s initial Business Combination, the last sale price of the Company’s common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the Company’s initial Business Combination or (B) the date on which the Company completes a liquidation, merger, stock exchange or other similar transaction after the initial Business Combination that results in all of the Company’s stockholders having the right to exchange their shares of common stock for cash, securities or other property (the “Lock Up Period”).

 

Private Placement Warrants

 

Upon the closing of the Public Offering on November 21, 2017, the Sponsor paid the Company $8,750,000 for the private placement purchase from the Company of 17,500,000 warrants at $0.50 per warrant (the “Private Placement Warrants”). Each Private Placement Warrant entitles the holder to purchase one-half of one share of Class A common stock at $5.75 ($11.50 per whole share). A portion of the purchase price of the Private Placement Warrants has been added to the proceeds from the Public Offering held in the Trust Account pending completion of the Company’s initial Business Combination. The Private Placement Warrants (including the common stock issuable upon exercise of the Private Placement Warrants) are not transferable, assignable or salable until 30 days after the completion of the initial Business Combination and are non-redeemable so long as they are held by the Sponsor or its permitted transferees. If the Private Placement Warrants are held by someone other than the Sponsor or its permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the warrants included in the Units being sold in the Public Offering. Otherwise, the Private Placement Warrants have terms and provisions that are identical to those of the Warrants sold as part of the Units in the Public Offering and have no net cash settlement provisions.

 

F-14

 

 

If the Company does not complete a Business Combination within the required time period, then the proceeds will be part of the liquidating distribution to the public stockholders and the Warrants issued to the Sponsor will expire worthless.

 

Registration Rights

 

The Company’s initial stockholder and holders of the Private Placement Warrants are entitled to registration rights (in the case of the Founder Shares, only after conversion to shares of Class A common stock) pursuant to a registration rights agreement dated November 16, 2017. The Company’s initial stockholder and holders of the Private Placement Warrants are entitled to make up to three demands, excluding short form registration demands, that the Company register such securities for sale under the Securities Act. In addition, these holders have “piggy-back” registration rights to include their securities in other registration statements filed by the Company. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

 

Administrative Service Agreement and Services Agreement

 

The Company pays $10,000 a month ($120,000 for each of the years ended December 31, 2019 and 2018) for office space, accounting services, utilities and secretarial support provided by the Sponsor subsequent to the date the Company’s securities were first listed on the NYSE. Such monthly fee will terminate upon the earlier of the consummation by the Company of an initial Business Combination or the liquidation of the Company. No amounts were payable at December 31, 2018 or 2019.

 

NOTE 6 – TRUST ACCOUNT AND FAIR VALUE MEASUREMENT

 

The Company complies with FASB ASC 820, Fair Value Measurements, for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually.

 

Upon the closing of the Public Offering and the private placement, a total of $300,000,000 was deposited into the Trust Account. All proceeds in the Trust Account may be invested in either U.S. government treasury bills with a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act of 1940, as amended, and that invest solely in U.S. government treasury obligations.

 

At December 31, 2019 the proceeds of the Trust Account were invested in a money market fund that invests solely in U.S. government treasury bills. At December 31, 2018 the proceeds of the Trust Account were invested in U.S. government treasury bills. The Company classifies its U.S. government treasury bills and equivalent securities as held-to-maturity in accordance with FASB ASC 320, “Investments – Debt and Equity Securities.” Held-to-maturity securities are those securities which the Company has the ability and intent to hold until maturity. Held-to-maturity U.S. government treasury bills are recorded at amortized cost on the accompanying December 31, 2018 balance sheet and adjusted for the amortization of discounts.

 

F-15

 

 

The following table presents information about the Company’s assets that are measured at fair value on a recurring basis as of December 31, 2019 and 2018 and indicates the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value. Since all of the Company’s permitted investments at December 31, 2019 and 2018 consist of U.S. government treasury bills or money market funds holding U.S. government treasury bills, fair values of its investments are determined by Level 1 inputs utilizing quoted prices (unadjusted) in active markets for identical assets or liabilities as follows:

 

           Quoted Price 
   Carrying value at       Prices in 
   December 31,   Gross Unrealized   Active Markets 
Description  2019   Holding Gain   (Level 1) 
Assets:            
Cash and money market  $302,529,000   $
       -
   $302,529,000 

 

           Quoted Price 
   Carrying value at       Prices in 
   December 31,   Gross Unrealized   Active Markets 
Description  2018   Holding Loss   (Level 1) 
Assets:            
Cash and money market  $1,000   $
-
   $1,000 
U.S. government treasury bills   304,034,000    (7,000)   304,027,000 
Total  $304,035,000   $(7,000)  $304,028,000 

 

On October 22, 2019, in connection with the Extension Amendment, stockholders elected to redeem 694,820 public shares of the Company’s Class A common stock at approximately $10.23 per share resulting in a distribution from the Trust Account of approximately $7,108,000. Additionally, during the year ended December 31, 2019, the Company received approximately $1,758,000 (two payments of approximately $879,000) from the Seller representing the payment of $0.03 per outstanding public share (29,305,180 public shares) for each extension period under the Extension Amendment discussed further in Note 2. Subsequent to December 31, 2019, the Company has extended the date by which it has to consummate a business combination from January 21, 2020 to February 20, 2020, and from February 20, 2020 to March 21, 2020. In connection with these extensions, the Seller loaned $979,155.40 and $879,155.40, respectively, to the Company under the Amended Seller Note. As a result of the extensions, the Seller has loaned to the Company a total aggregate amount of approximately $3,816,621.60.

 

During the year ended December 31, 2019, the Company withdrew approximately $2,638,000 from the Trust Account in order to pay 2018 actual and 2019 estimated income taxes (approximately $1,397,000) and franchise taxes (approximately $420,000) paid in installments and to release approximately $813,000 allowed for working capital (including undistributed amounts from the prior year). The Company may continue to withdraw from the Trust Account amounts necessary for taxes, and for working capital of up to $750,000 annually (on a pro rata basis), during the period of the Extension Amendment.

 

During the year ended December 31, 2018 the Company withdrew an aggregate of approximately $1,927,000 from the Trust Account including approximately $750,000 for working capital and approximately $1,177,000 for payment of federal income and state franchise taxes, including estimated taxes.

 

NOTE 7 – STOCKHOLDERS’ EQUITY

 

Common Stock

 

The authorized common stock of the Company is 110,000,000 shares, including 100,000,000 shares of Class A common stock, par value $0.0001, and 10,000,000 shares of Class F common stock, par value $0.0001. Upon completion of the Public Offering, the Company will likely (depending on the terms of the initial Business Combination) be required to increase the number of shares of common stock which it is authorized to issue at the same time as its stockholders vote on the Business Combination to the extent the Company seeks stockholder approval in connection with its initial Business Combination. Holders of the Company’s common stock vote together as a single class and are entitled to one vote for each share of common stock.

 

F-16

 

 

In October 2016, the Sponsor purchased 8,625,000 shares of Class F common stock (the “Founder Shares”) for $25,000, or approximately $0.004 per share. The Sponsor had agreed to forfeit up to 1,125,000 Founder Shares to the extent that the over-allotment option is not exercised in full by the underwriters. The forfeiture would be adjusted to the extent that the over-allotment option is not exercised in full by the underwriters so that the initial stockholder will own 20% of the Company’s issued and outstanding shares after the Public Offering. On November 27, 2017, the Company was advised by the underwriters’ that the overallotment option would not be exercised. As such, the 1,125,000 shares subject to forfeiture were forfeited.

 

On October 22, 2019, in connection with the Extension Amendment, stockholders elected to redeem 694,820 shares of the Company’s Class A common stock, par value $0.0001 per share, issued in the Company’s initial public offering (the “public shares”). The shares were redeemed at $10.23 per share, the per share value of the Trust Account at that date resulting in a distribution from the Trust Account of approximately $7,108,000. As a result, 29,305,180 public shares remain issued and outstanding following such redemptions.

 

At each of December 31, 2019 and 2018 there were 7,500,000 shares of Class F common stock issued and outstanding. At December 31, 2019 and 2018 there were 29,305,180 and 30,000,000 shares, respectively, of Class A common stock outstanding (28,344,013 and 28,916,141, respectively, of which are classified outside of equity as redeemable common stock).

 

Preferred Stock

 

The Company is authorized to issue 1,000,000 shares of preferred stock, par value $0.0001, with such designations, voting and other rights and preferences as may be determined from time to time by the Board of Directors. At December 31, 2019 and 2018, the rights and preferences have not been determined and there were no shares of preferred stock issued and outstanding.

 

F-17

 

 

PART IV

 

ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES

 

(a) The following documents are filed as part of this Amendment No. 1 to the Annual Report on Form 10-K:

 

Financial Statements: See “Index to Financial Statements” at “Item 8. Financial Statements and Supplementary Data” herein.

 

(b) Exhibits:

 

Information in response to this Item is incorporated herein by reference to the Exhibit Index to this Amendment No. 1 to Form 10-K.

 

ITEM 16. FORM 10-K SUMMARY

 

None.

 

5

 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this Amendment No. 1 to the Annual Report on Form 10-K to be signed on its behalf by the undersigned, thereunto duly authorized on this 30th day of October, 2020.

 

  LEGACY ACQUISITION CORP.
   
  By: /s/ Edwin J. Rigaud
    Name: Edwin J. Rigaud
    Title:  Chief Executive Officer and Chairman

 

 

6

 

 

EXHIBIT INDEX

 

Exhibit No.   Description   Incorporation by Reference
2.1   Share Exchange Agreement, dated as of August 23, 2019, by and between the Company and Blue Valor Limited.   Incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K filed on August 27, 2019.
2.2   First Amendment to Share Exchange Agreement, dated as of September 27, 2019, by and between the Company and Blue Valor Limited.   Incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K filed on October 8, 2019.
2.3   Amended and Restated Share Exchange Agreement, dated as of December 2, 2019, by and between Blue Valor Limited, a company incorporated in Hong Kong and an indirect, wholly-owned subsidiary of Blue Focus Intelligent Communications Group Ltd. and the Company.   Incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K filed on December 2, 2019.
3.1  

Amended and Restated Certificate of Incorporation of the Company, as filed with the Secretary of State of the State of Delaware on November 16, 2017.

 

Incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on November 22, 2017.

3.2   Certificate of Correction to the Amended and Restated Certificate of Incorporation, as filed with the Secretary of State of the State of Delaware on November 20, 2017.   Incorporated by reference to Exhibit 3.2 to the Company’s Current Report on Form 8-K filed on November 22, 2017.
3.3   Bylaws of the Company.   Incorporated by reference to Exhibit 3.3 to the Company’s Registration Statement on Form S-1 (File No. 333-221116) filed with the Securities and Exchange Commission on October 25, 2017.
3.4   Amendment to Amended and Restated Certificate of Incorporation.   Incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on October 23, 2019.
4.1   Specimen Unit certificate.   Incorporated by reference to Exhibit 4.1 to Amendment No. 1 to the Company’s Registration Statement on Form S-1 (File No. 333-221116) filed with the Securities and Exchange Commission on November 8, 2017.
4.2   Specimen Class A common stock Certificate.   Incorporated by reference to Exhibit 4.2 to Amendment No. 1 to the Company’s Registration Statement on Form S-1 (File No. 333-221116) filed with the Securities and Exchange Commission on November 8, 2017.
4.3   Specimen Warrant Certificate.   Incorporated by reference to Exhibit 4.2 to Amendment No. 1 to the Company’s Registration Statement on Form S-1 (File No. 333-221116) filed with the Securities and Exchange Commission on November 8, 2017.
4.4   Warrant Agreement, dated as of November 16, 2017 by and between the Company and Continental Stock Transfer & Trust Company, a New York corporation, as warrant agent.   Incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed on November 22, 2017.
4.5   See Exhibit 3.1 and 3.2 for provisions of the Amended and Restated Certificate of Incorporation of the Company defining the rights of holders of the Class A common stock of the Company.   Incorporated by reference to Exhibits 3.1 and 3.2 to the Company’s Current Report on Form 8-K filed on November 22, 2017.
4.6   See Exhibit 3.3 for provisions of the Amended and Restated By-Laws, as amended, of the Company defining the rights of holders of the Class A common stock of the Company.   Incorporated by reference to Exhibits 3.3 to the Company’s Registration Statement on Form S-1 (File No. 333-221116) filed with the Securities and Exchange Commission on October 25, 2017.
4.7  

Description of Securities

 

Incorporated by reference to the Original Filing.

10.1   Investment Management Trust Account Agreement, dated as of November 16, 2017, between Continental Stock Transfer & Trust Company and the Company.   Incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on November 22, 2017.

 

7

 

 

Exhibit No.   Description   Incorporation by Reference
10.2   Registration Rights Agreement, dated as of November 16, 2017, by and among the Company and the initial security holders.   Incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on November 22, 2017.
10.3   Letter Agreement, dated as of November 16, 2017. by and between the Company, the initial security holders and the officers and directors of the Company.   Incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K filed on November 22, 2017.
10.4   Amended and Restated Promissory Note, dated October 20, 2017, issued to Legacy Acquisition Sponsor I LLC   Incorporated by reference to Exhibit 10.1 to the Company’s Registration Statement on Form S-1 (File No. 333-221116) filed with the Securities and Exchange Commission on October 25, 2017.
10.5   Securities Subscription Agreement, dated October 16, 2016, between the Registrant and Legacy Acquisition Sponsor I LLC.   Incorporated by reference to Exhibit 10.5 to the Company’s Registration Statement on Form S-1 (File No. 333-221116) filed with the Securities and Exchange Commission on October 25, 2017.
10.6   Sponsor Warrants Purchase Agreement effective as of October 24, 2017, between the Registrant and Legacy Acquisition Sponsor I LLC.   Incorporated by reference to Exhibit 10.6 to the Company’s Registration Statement on Form S-1 (File No. 333-221116) filed with the Securities and Exchange Commission on October 25, 2017.
10.7   Administrative Services Agreement, dated as of November 16, 2017, by and among the Company and Legacy Acquisition Sponsor I LLC.   Incorporated by reference to Exhibit 10.7 to the Company’s Annual Report on Form 10-K (File No. 001-38296) filed with the Securities and Exchange Commission on March 29, 2018.
10.8   Form of Indemnity Agreement   Incorporated by reference to Exhibit 10.7 to Amendment No. 1 to the Company’s Registration Statement on Form S-1 (File No. 333-221116) filed with the Securities and Exchange Commission on November 8, 2017.
10.9   Amendment No. 1 to Investment Management Trust Agreement dated October 22, 2019 by and between the Company and Continental Stock Transfer & Trust Company.   Incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on October 23, 2019.
10.10   Promissory Note dated as of October 23, 2019 issued by the Company to Blue Valor Limited.   Incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on October 29, 2019.
10.11   Share Redemption Agreement, dated as of December 2, 2019, by and between Blue Valor Limited, a company incorporated in Hong Kong, and an indirect, wholly owned subsidiary of BlueFocus Intelligent Communications Group Co. Ltd., Legacy Acquisition Sponsor I LLC and the Company.   Incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on December 2, 2019.
10.15   Promissory Note dated as of December 17, 2019 issued by the Company to Blue Valor Limited   Incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on December 23, 2019.
24   Powers of Attorney   Incorporated by reference to the Original Filing.
31.1   Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.   Filed herewith.
31.2   Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.   Filed herewith.
32.1   Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.   Furnished herewith.
32.2   Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.   Furnished herewith.
101.INS   XBRL Instance Document   Filed herewith.
101.SCH   XBRL Taxonomy Extension Schema Document   Filed herewith.
101.CAL   XBRL Taxonomy Extension Calculation Linkbase Document   Filed herewith.
101.LAB   XBRL Taxonomy Extension Labels Linkbase Document   Filed herewith.
101.PRE   XBRL Taxonomy Extension Presentation Linkbase Document   Filed herewith.
101.DEF   XBRL Taxonomy Extension Definition Linkbase Document   Filed herewith.

 

 

8

 
001-37509 true FY 0001698113 0001698113 2019-01-01 2019-12-31 0001698113 lgc:ClassFCommonStockMember 2020-02-14 0001698113 us-gaap:CommonClassAMember 2020-02-14 0001698113 2019-06-28 0001698113 2019-12-31 0001698113 2018-12-31 0001698113 us-gaap:CommonClassAMember 2019-12-31 0001698113 us-gaap:CommonClassAMember 2018-12-31 0001698113 lgc:CommonClassFMember 2019-12-31 0001698113 lgc:CommonClassFMember 2018-12-31 0001698113 2018-01-01 2018-12-31 0001698113 us-gaap:CommonClassAMember 2019-01-01 2019-12-31 0001698113 us-gaap:CommonClassAMember 2018-01-01 2018-12-31 0001698113 lgc:CommonClassFMember 2019-01-01 2019-12-31 0001698113 lgc:CommonClassFMember 2018-01-01 2018-12-31 0001698113 us-gaap:CommonClassAMember 2017-12-31 0001698113 lgc:CommonClassFMember 2017-12-31 0001698113 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001698113 us-gaap:RetainedEarningsMember 2017-12-31 0001698113 2017-12-31 0001698113 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-12-31 0001698113 us-gaap:RetainedEarningsMember 2018-01-01 2018-12-31 0001698113 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001698113 us-gaap:RetainedEarningsMember 2018-12-31 0001698113 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-12-31 0001698113 us-gaap:RetainedEarningsMember 2019-01-01 2019-12-31 0001698113 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001698113 us-gaap:RetainedEarningsMember 2019-12-31 0001698113 us-gaap:IPOMember 2017-11-01 2017-11-16 0001698113 us-gaap:PrivatePlacementMember 2017-11-01 2017-11-16 0001698113 lgc:PublicOfferingAndPrivatePlacementMember 2019-12-31 0001698113 lgc:PublicOfferingAndPrivatePlacementMember 2019-01-01 2019-12-31 0001698113 us-gaap:CommonStockMember 2019-12-31 0001698113 2019-10-01 2019-10-23 0001698113 2019-12-02 2019-12-21 0001698113 2019-10-01 2019-10-31 0001698113 us-gaap:CommonClassAMember 2019-10-01 2019-10-31 0001698113 2019-10-31 0001698113 us-gaap:IPOMember 2017-11-01 2017-11-21 0001698113 us-gaap:IPOMember 2017-11-21 0001698113 us-gaap:CommonStockMember us-gaap:IPOMember 2017-11-21 0001698113 us-gaap:CommonStockMember 2017-11-21 0001698113 us-gaap:WarrantMember us-gaap:IPOMember 2019-01-01 2019-12-31 0001698113 us-gaap:OverAllotmentOptionMember 2019-01-01 2019-12-31 0001698113 us-gaap:IPOMember 2019-01-01 2019-12-31 0001698113 us-gaap:CommonClassAMember 2019-10-01 2019-10-22 0001698113 lgc:SponsorMember lgc:FounderSharesMember 2016-10-01 2016-10-31 0001698113 lgc:SponsorMember lgc:FounderSharesMember 2016-10-31 0001698113 lgc:FounderSharesMember us-gaap:OverAllotmentOptionMember 2017-11-01 2017-11-27 0001698113 lgc:SponsorMember us-gaap:PrivatePlacementMember 2017-11-01 2017-11-21 0001698113 lgc:SponsorMember us-gaap:PrivatePlacementMember 2017-11-21 0001698113 2019-10-02 2019-10-22 0001698113 us-gaap:MoneyMarketFundsMember 2019-12-31 0001698113 us-gaap:MoneyMarketFundsMember 2019-01-01 2019-12-31 0001698113 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2019-12-31 0001698113 us-gaap:MoneyMarketFundsMember 2018-12-31 0001698113 us-gaap:MoneyMarketFundsMember 2018-01-01 2018-12-31 0001698113 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member 2018-12-31 0001698113 us-gaap:USTreasurySecuritiesMember 2018-12-31 0001698113 us-gaap:USTreasurySecuritiesMember 2018-01-01 2018-12-31 0001698113 us-gaap:USTreasurySecuritiesMember us-gaap:FairValueInputsLevel1Member 2018-12-31 0001698113 us-gaap:FairValueInputsLevel1Member 2018-12-31 0001698113 lgc:SponsorMember us-gaap:CommonStockMember 2016-10-31 0001698113 lgc:SponsorMember us-gaap:OverAllotmentOptionMember 2017-11-01 2017-11-27 0001698113 us-gaap:CommonClassAMember 2019-10-22 0001698113 us-gaap:IPOMember 2019-10-22 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure